TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Research reports on immunization from Novartis provide new insights
May 12th, 2009
"Immune responses to vaccination are tested in clinical trials. This process usually requires years especially when immune memory and persistence are analyzed," scientists writing in the journal Proceedings of the National Academy of Sciences of the United States of America report. "Markers able to quickly predict the immune response would be very useful, particularly when dealing with emerging diseases that require a rapid response, such as avian influenza. To address this question we vaccinated healthy adults at days 1, 22, and 202 with plain or MF59-adjuvanted H5N1 subunit vaccines and tested both cell-mediated and antibody responses up to day 382. Only the...
Source: TB & Outbreaks Week (2009-05-12)
|
